Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 8

Supplemental vitamin D and physical performance in COPD: a pilot randomized trial

Authors Bjerk SM, Edgington BD, Rector TS, Kunisaki KM

Received 29 November 2012

Accepted for publication 11 January 2013

Published 15 February 2013 Volume 2013:8 Pages 97—104

DOI https://doi.org/10.2147/COPD.S40885

Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 5

Sonja M Bjerk,1 Bradley D Edgington,1 Thomas S Rector,1,2 Ken M Kunisaki1,2

1University of Minnesota, 2Minneapolis VA Health Care System, Minneapolis, MN, USA

Background: Low 25-hydroxyvitamin D (25[OH]D) levels, commonly observed in chronic obstructive pulmonary disease (COPD), are associated with muscle weakness in elderly populations, and vitamin D supplementation appears to improve muscle strength and decrease falls in older individuals. We tested the effect of vitamin D supplementation on physical performance in patients with COPD.
Methods: Patients were randomized to daily cholecalciferol (2000 IU) or placebo for 6 weeks. The primary outcome was the 6-week change in Short Physical Performance Battery (SPPB) score. Secondary outcomes included changes in the St George’s Respiratory Questionnaire (SGRQ) score, and serum 25(OH)D.
Results: Thirty-six participants (mean age 68 years, all Caucasian males, mean forced expiratory volume in one second 33% of predicted) completed the study. Despite an increase in 25(OH)D levels in the intervention arm to a mean of 32.6 ng/mL (versus 22.1 ng/mL in the placebo arm), there was no difference in improvements in either SPPB scores (0.3 point difference; 95% confidence interval -0.8 to 1.5; P = 0.56) or SGRQ scores (2.3 point difference; 95% confidence interval -2.3 to 6.9; P = 0.32).
Conclusion: Among patients with severe COPD, 2000 IU of daily vitamin D for 6 weeks increased 25(OH)D to a level widely considered as normal. However, compared with placebo, short-term vitamin D supplementation had no discernible effect on a simple measure of physical performance.

Keywords: chronic obstructive pulmonary disease, randomized controlled trial, vitamin D, skeletal muscle strength

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]

 

Other article by this author:

Readers of this article also read:

Multimodal intervention improves fatigue and quality of life in subjects with progressive multiple sclerosis: a pilot study [Corrigendum]

Bisht B, Darling WG, Shivapour ET, Lutgendorf SK, Snetselaar LG, Chenard CA, Wahls TL

Degenerative Neurological and Neuromuscular Disease 2015, 5:91-92

Published Date: 10 September 2015

Antibiotic and chemotherapeutic enhanced three-dimensional printer filaments and constructs for biomedical applications

Weisman JA, Nicholson JC, Tappa K, Jammalamadaka UB, Wilson CG, Mills DK

International Journal of Nanomedicine 2015, 10:357-370

Published Date: 9 January 2015

Sentinel lymph node biopsy for conjunctival malignant melanoma: surgical techniques

Wainstein AJA, Drummond-Lage AP, Kansaon MJM, Bretas GO, Almeida RF, Gloria ALF, Figueiredo ARP

Clinical Ophthalmology 2015, 9:1-6

Published Date: 16 December 2014

Support for the initial attachment, growth and differentiation of MG-63 cells: a comparison between nano-size hydroxyapatite and micro-size hydroxyapatite in composites

Filová E, Suchý T, Sucharda Z, Šupová M, Žaloudková M, Balík K, Lisá V, Šlouf M, Bačáková L

International Journal of Nanomedicine 2014, 9:3687-3706

Published Date: 6 August 2014

Future developments in health care performance management

Crema M, Verbano C

Journal of Multidisciplinary Healthcare 2013, 6:415-421

Published Date: 13 November 2013

Role of indacaterol and the newer very long-acting β2-agonists in patients with stable COPD: a review

Ridolo E, Montagni M, Olivieri E, Riario-Sforza GG, Incorvaia C

International Journal of Chronic Obstructive Pulmonary Disease 2013, 8:425-432

Published Date: 18 September 2013